A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.


Updates from The Motley Fool

Latest updates on Orexigen Therapeutics from Fool.com.  The Fool has written over 200 articles on Orexigen Therapeutics.
Obesity Drugs: Stocks to Watch

Obesity is now considered one of the most serious threats to global health today. To combat this ...



Stock Performance

View Interactive OREX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Orexigen Therapeutics.
Current Price: $0.00
Prev Close: $0.00
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.00 - $0.00
Volume: 0
Avg Vol 0
Market Cap: $0
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Michael A. Narachi, CEO

100% Approve

Based on 7 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Orexigen Therapeutics.

A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers